Vial
MARCH 1, 2024
The growing demand for CRO services is fueled by the high costs of in-house drug discovery and development, the increasing number of products in the development pipeline, tech advancements, and the growing focus on precision and personalized medicine. billion by 2029. launched a PV platform for clinical research registries.
Drug Discovery World
OCTOBER 4, 2022
As it stands, there are currently 19 gene therapies approved for clinical use, alongside 18 RNA therapies and 59 non-genetically modified cell therapies, according to the Q2 report by the American Society of Cell & Gene Therapy. Collaborations have and will always be an important part of this industry. Sustainability in drug discovery.
Expert insights. Personalized for you.
52 
Let's personalize your content